April 2014

The U.S. Food and Drug Administration (“FDA”) recently issued three Warning Letters, all related to issues involving clinical trials.

All three letters were critical of the Institutional Review Boards (“IRBs”) charged with overseeing the clinical trials.

The first Warning Letter

Recent bipartisan legislation introduced into the US House of Representatives by House Budget Committee Chairman Paul Ryan (R-Wis) and Representative Ron Kind (D-Wis) entitled “Expanding the Availability of Medicare Data Act” (H.R. 4418) would expand the availability of Medicare claims

On April 9, 2014, Republican Mike Pompeo of Kansas and Democrat G.K. Butterfield of North Carolina introduced the “Safe and Accurate Food Labeling Act of 2014.” The new bill, H.R. 4432, seeks to regulate the labeling of bioengineered food under

On April 17th, President Obama announced that eight million people signed up for private health insurance coverage through the insurance marketplaces established by the Affordable Care Act (“ACA”) during the open enrollment period of October 1st through March 31st.  This